Literature DB >> 27812952

Predictors of Poor Outcome in ANCA-Associated Vasculitis (AAV).

Luis E Vega1, Luis R Espinoza2.   

Abstract

It is important to recognize factors that might predict poor outcome and prognosis in patients with AAV. The predictors reported in the literature encompass genetic, histopathological, and clinical ones. Genetic studies (genetic predictors) have found genes that are associated with prediction of poor response to treatment, deterioration of renal function, and risk of mortality. Histopathological studies (histopathological predictors) have shown that sclerotic renal lesions are associated with increased risk of progression to end-stage renal disease and death. Lastly, scores (clinical predictors) obtained with tool as FFS, Maldini risk score, VDI, and emerging new biomarkers could potentially be helpful in assessment of prognosis in the future.

Entities:  

Keywords:  ANCA-associated vasculitis; Biomarkers; Eosinophilic granulomatosis with polyangiitis; Granulomatosis with polyangiitis; Microscopic polyangiitis; Poor outcome

Mesh:

Year:  2016        PMID: 27812952     DOI: 10.1007/s11926-016-0619-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  37 in total

Review 1.  Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases.

Authors:  C Ponte; J Sznajd; L O'Neill; R A Luqmani
Journal:  Clin Exp Rheumatol       Date:  2014-10-30       Impact factor: 4.473

2.  Circulating microRNA expression pattern separates patients with anti-neutrophil cytoplasmic antibody associated vasculitis from healthy controls.

Authors:  C Skoglund; A L Carlsen; M Weiner; T Kurz; Thomas Hellmark; P Eriksson; N H H Heegaard; M Segelmark
Journal:  Clin Exp Rheumatol       Date:  2015-05-26       Impact factor: 4.473

3.  Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Sebastian Unizony; Noha Lim; Deborah J Phippard; Vincent J Carey; Eli M Miloslavsky; Nadia K Tchao; David Iklé; Adam L Asare; Peter A Merkel; Paul A Monach; Philip Seo; E William St Clair; Carol A Langford; Robert Spiera; Gary S Hoffman; Cees G M Kallenberg; Ulrich Specks; John H Stone
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

4.  Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease.

Authors:  Yali Cao; Zhigang Tian; Wenge Li; Li Ma; Yongchao Yu; Wenwen Ren
Journal:  J Rheumatol       Date:  2014-03-15       Impact factor: 4.666

5.  A candidate gene approach to ANCA-associated vasculitis reveals links to the C3 and CTLA-4 genes but not to the IL1-Ra and Fcγ-RIIa genes.

Authors:  Ulf Persson; Birgitta Gullstrand; Asa Pettersson; Gunnar Sturfelt; Lennart Truedsson; Mårten Segelmark
Journal:  Kidney Blood Press Res       Date:  2013-12-14       Impact factor: 2.687

6.  Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.

Authors:  Peter C Grayson; Paul A Monach; Christian Pagnoux; David Cuthbertson; Simon Carette; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Kathleen Maksimowicz-McKinnon; Philip Seo; Ulrich Specks; Steven R Ytterberg; Peter A Merkel
Journal:  Rheumatology (Oxford)       Date:  2014-11-17       Impact factor: 7.580

7.  Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?

Authors:  A W S de Souza; W H Abdulahad; P Sosicka; J Bijzet; P C Limburg; C A Stegeman; M Bijl; J Westra; C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

8.  A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.

Authors:  Shivani Shah; John Havill; M Hafizur Rahman; Duvuru Geetha
Journal:  Clin Rheumatol       Date:  2015-10-07       Impact factor: 2.980

9.  Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  E M Miloslavsky; U Specks; P A Merkel; P Seo; R Spiera; C A Langford; G S Hoffman; C G M Kallenberg; E W St Clair; N K Tchao; L Viviano; L Ding; L P Sejismundo; K Mieras; D Iklé; B Jepson; M Mueller; P Brunetta; N B Allen; F C Fervenza; D Geetha; K Keogh; E Y Kissin; P A Monach; T Peikert; C Stegeman; S R Ytterberg; J H Stone
Journal:  Arthritis Rheum       Date:  2013-09

10.  Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis.

Authors:  Tidi M Hassan; Astrid S Hassan; Ann Igoe; Mark Logan; Cedric Gunaratnam; Noel G McElvaney; Shane J O'Neill
Journal:  BMC Immunol       Date:  2014-05-27       Impact factor: 3.615

View more
  5 in total

Review 1.  Eosinophilic Vasculitis.

Authors:  Karen L Vega Villanueva; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2020-01-11       Impact factor: 4.592

Review 2.  Anti-neutrophil cytoplasmic antibodies and their clinical significance.

Authors:  Supaporn Suwanchote; Muanpetch Rachayon; Pongsawat Rodsaward; Jongkonnee Wongpiyabovorn; Tawatchai Deekajorndech; Helen L Wright; Steven W Edwards; Michael W Beresford; Pawinee Rerknimitr; Direkrit Chiewchengchol
Journal:  Clin Rheumatol       Date:  2018-03-10       Impact factor: 2.980

3.  Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis.

Authors:  Daishi Hirano; Tomoaki Ishikawa; Aya Inaba; Mai Sato; Tomohiro Shinozaki; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2019-05-10       Impact factor: 3.714

4.  Antineutrophil cytoplasmic antibodies and their relationship with disease activity and presence of staphylococcal superantigens in nasal swabs in patients having granulomatosis with polyangiitis: results of a study involving 115 patients from a single center.

Authors:  Justyna Fijolek; E Wiatr; V Petroniec; E Augustynowicz-Kopec; M Bednarek; D Gawryluk; K Roszkowski-Sliz
Journal:  Clin Rheumatol       Date:  2019-07-23       Impact factor: 2.980

5.  Thoracic manifestation of Wegener's granulomatosis: Computed tomography findings and analysis of misdiagnosis.

Authors:  Jiakai Li; Chuangui Li; Jiaojiao Li
Journal:  Exp Ther Med       Date:  2018-05-11       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.